InhaleRx Ltd: Jun24 Quarterly Activities Report
InhaleRx Ltd: Jun24 Appendix 4C Cash Flow Report
InhaleRx Ltd: Live Investor Webinar
InhaleRx Ltd: IRX616a IND Application Outcome
InhaleRx Ltd: Final Clinical Study Report Received, Phase 1 IRX-211
InhaleRx Ltd: Change of Director's Interest Notice - Sean Williams
InhaleRx Ltd: Notification regarding unquoted securities - IRX
InhaleRx Ltd: AGM Results
InhaleRx Ltd: 2024 AGM Slides
InhaleRx Ltd: Significant Milestone - IND submitted to the FDA for IRX616a
InhaleRx Ltd: Mar24 Appendix 4C Cash Flow Report
InhaleRx Ltd: Mar24 Quarterly Activities Report
InhaleRx Ltd: AGM Access Letter
InhaleRx Ltd: AGM Sample Proxy Form
InhaleRx Ltd: Notice of Annual General Meeting
InhaleRx Ltd: Change of Registered Office Address
InhaleRx Ltd: Proposed issue of securities - IRX
InhaleRx Ltd: Appendix 4G
InhaleRx Ltd: Corporate Governance Statement and Appendix 4G
InhaleRx Ltd: Annual Report to shareholders
No Data